COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases

COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases is a phase 2/3, randomised interventional study registered as NCT06185556 by Amsterdam UMC, location VUmc, with a registry enrolment figure of 78 participants, started 2024-08-20 and due to reach its primary completion in 2029-09-01. Interventions recorded: Irreversible electroporation; Stereotactic body radiotherapy. Conditions listed: Colorectal Cancer; Liver Metastases; Liver Metastasis Colon Cancer; Unresectable Solid Tumor. Primary outcome: Local control. Colorectal eligibility wording from the registry: "* Histological documentation of primary colorectal tumor is available;". Sites: Netherlands. No results are recorded here; the registry entry is the source.